The Mechanism of Action and Clinical Application Progress of Apigenin in the Treatment of Liver Diseases
Textile & Leather Review · 27.04.2026 · 9 · 4545-4556
DOI: 10.31881/tlr.2026.4545 ↗Kurz gefasst
Fachartikel in der Zeitschrift Textile & Leather Review, online erschienen am 27.04.2026. Verfasst von Zhiming Wei und 1 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
Apigenin, as a natural flavonoid compound, is widely present in various fruits, vegetables, and herbal medicines. In recent years, numerous studies have shown that apigenin exhibits significant potential in multiple liver diseases through various pathways such as anti-inflammation, antioxidation, anti-fibrosis, regulation of lipid metabolism, induction of autophagy and apoptosis. This article elaborates on the pharmacological mechanisms and clinical application progress of apigenin in major liver diseases including non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD), liver fibrosis, liver cancer, and drug-induced liver injury, and also looks forward to future research directions, aiming to provide a basis for the in-depth exploration of apigenin as a therapeutic drug for liver diseases.
Zitieren
APA
Wei, Z., & Wu, Y. (2026). The Mechanism of Action and Clinical Application Progress of Apigenin in the Treatment of Liver Diseases. Textile & Leather Review, 9, 4545-4556. https://doi.org/10.31881/tlr.2026.4545
Vancouver
Wei Z, Wu Y. The Mechanism of Action and Clinical Application Progress of Apigenin in the Treatment of Liver Diseases. Textile & Leather Review. 2026;9:4545-4556. doi:10.31881/tlr.2026.4545
BibTeX
@article{Wei2026,
author = {Wei, Zhiming and Wu, Yakun},
title = {The Mechanism of Action and Clinical Application Progress of Apigenin in the Treatment of Liver Diseases},
journal = {Textile & Leather Review},
year = {2026},
volume = {9},
pages = {4545--4556},
doi = {10.31881/tlr.2026.4545}
}
EUVIMED